These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
156 related articles for article (PubMed ID: 20208150)
1. Structural implications of a G170R mutation of alanine:glyoxylate aminotransferase that is associated with peroxisome-to-mitochondrion mistargeting. Djordjevic S; Zhang X; Bartlam M; Ye S; Rao Z; Danpure CJ Acta Crystallogr Sect F Struct Biol Cryst Commun; 2010 Mar; 66(Pt 3):233-6. PubMed ID: 20208150 [TBL] [Abstract][Full Text] [Related]
2. Alanine:glyoxylate aminotransferase peroxisome-to-mitochondrion mistargeting in human hereditary kidney stone disease. Danpure CJ; Lumb MJ; Birdsey GM; Zhang X Biochim Biophys Acta; 2003 Apr; 1647(1-2):70-5. PubMed ID: 12686111 [TBL] [Abstract][Full Text] [Related]
3. Human liver peroxisomal alanine:glyoxylate aminotransferase: Different stability under chemical stress of the major allele, the minor allele, and its pathogenic G170R variant. Cellini B; Lorenzetto A; Montioli R; Oppici E; Voltattorni CB Biochimie; 2010 Dec; 92(12):1801-11. PubMed ID: 20713123 [TBL] [Abstract][Full Text] [Related]
4. Functional synergism between the most common polymorphism in human alanine:glyoxylate aminotransferase and four of the most common disease-causing mutations. Lumb MJ; Danpure CJ J Biol Chem; 2000 Nov; 275(46):36415-22. PubMed ID: 10960483 [TBL] [Abstract][Full Text] [Related]
5. Four of the most common mutations in primary hyperoxaluria type 1 unmask the cryptic mitochondrial targeting sequence of alanine:glyoxylate aminotransferase encoded by the polymorphic minor allele. Fargue S; Lewin J; Rumsby G; Danpure CJ J Biol Chem; 2013 Jan; 288(4):2475-84. PubMed ID: 23229545 [TBL] [Abstract][Full Text] [Related]
6. Translation inhibition corrects aberrant localization of mutant alanine-glyoxylate aminotransferase: possible therapeutic approach for hyperoxaluria. Belostotsky R; Lyakhovetsky R; Sherman MY; Shkedy F; Tzvi-Behr S; Bar R; Hoppe B; Reusch B; Beck BB; Frishberg Y J Mol Med (Berl); 2018 Jul; 96(7):621-630. PubMed ID: 29777253 [TBL] [Abstract][Full Text] [Related]
7. Crystal structure of alanine:glyoxylate aminotransferase and the relationship between genotype and enzymatic phenotype in primary hyperoxaluria type 1. Zhang X; Roe SM; Hou Y; Bartlam M; Rao Z; Pearl LH; Danpure CJ J Mol Biol; 2003 Aug; 331(3):643-52. PubMed ID: 12899834 [TBL] [Abstract][Full Text] [Related]
8. Inhibition of alanine:glyoxylate aminotransferase 1 dimerization is a prerequisite for its peroxisome-to-mitochondrion mistargeting in primary hyperoxaluria type 1. Leiper JM; Oatey PB; Danpure CJ J Cell Biol; 1996 Nov; 135(4):939-51. PubMed ID: 8922378 [TBL] [Abstract][Full Text] [Related]
9. Mammalian alanine/glyoxylate aminotransferase 1 is imported into peroxisomes via the PTS1 translocation pathway. Increased degeneracy and context specificity of the mammalian PTS1 motif and implications for the peroxisome-to-mitochondrion mistargeting of AGT in primary hyperoxaluria type 1. Motley A; Lumb MJ; Oatey PB; Jennings PR; De Zoysa PA; Wanders RJ; Tabak HF; Danpure CJ J Cell Biol; 1995 Oct; 131(1):95-109. PubMed ID: 7559790 [TBL] [Abstract][Full Text] [Related]
10. Correction of an enzyme trafficking defect in hereditary kidney stone disease in vitro. Lumb MJ; Birdsey GM; Danpure CJ Biochem J; 2003 Aug; 374(Pt 1):79-87. PubMed ID: 12737622 [TBL] [Abstract][Full Text] [Related]
11. Primary hyperoxaluria type 1: AGT mistargeting highlights the fundamental differences between the peroxisomal and mitochondrial protein import pathways. Danpure CJ Biochim Biophys Acta; 2006 Dec; 1763(12):1776-84. PubMed ID: 17027096 [TBL] [Abstract][Full Text] [Related]
12. Enzymological and mutational analysis of a complex primary hyperoxaluria type 1 phenotype involving alanine:glyoxylate aminotransferase peroxisome-to-mitochondrion mistargeting and intraperoxisomal aggregation. Danpure CJ; Purdue PE; Fryer P; Griffiths S; Allsop J; Lumb MJ; Guttridge KM; Jennings PR; Scheinman JI; Mauer SM Am J Hum Genet; 1993 Aug; 53(2):417-32. PubMed ID: 8101040 [TBL] [Abstract][Full Text] [Related]
13. Pharmacologic rescue of an enzyme-trafficking defect in primary hyperoxaluria 1. Miyata N; Steffen J; Johnson ME; Fargue S; Danpure CJ; Koehler CM Proc Natl Acad Sci U S A; 2014 Oct; 111(40):14406-11. PubMed ID: 25237136 [TBL] [Abstract][Full Text] [Related]
14. A unique molecular basis for enzyme mistargeting in primary hyperoxaluria type 1. Leiper JM; Danpure CJ Clin Chim Acta; 1997 Oct; 266(1):39-50. PubMed ID: 9435987 [TBL] [Abstract][Full Text] [Related]
15. The molecular basis of alanine: glyoxylate aminotransferase mistargeting: the most common single cause of primary hyperoxaluria type 1. Danpure CJ J Nephrol; 1998; 11 Suppl 1():8-12. PubMed ID: 9604801 [TBL] [Abstract][Full Text] [Related]
16. Insights into the pathogenesis of primary hyperoxaluria type I from the structural dynamics of alanine:glyoxylate aminotransferase variants. Vankova P; Pacheco-Garcia JL; Loginov DS; Gómez-Mulas A; Kádek A; Martín-Garcia JM; Salido E; Man P; Pey AL FEBS Lett; 2024 Feb; 598(4):485-499. PubMed ID: 38243391 [TBL] [Abstract][Full Text] [Related]
17. Role of low native state kinetic stability and interaction of partially unfolded states with molecular chaperones in the mitochondrial protein mistargeting associated with primary hyperoxaluria. Pey AL; Salido E; Sanchez-Ruiz JM Amino Acids; 2011 Nov; 41(5):1233-45. PubMed ID: 21103899 [TBL] [Abstract][Full Text] [Related]